Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia

A novel niosomal delivery system was designed and investigated for the targeted delivery of daunorubicin (DNR) against acute myeloid leukemia (AML). Anti-CD123 antibodies conjugated to Mal-PEG(2000)-DSPE were incorporated into normal niosomes (NS) via a post insertion method to afford antibody-modif...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fu-rong, Jin, Hui, Wang, Yin, Chen, Chen, Li, Ming, Mao, Sheng-jun, Wang, Qiantao, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244627/
https://www.ncbi.nlm.nih.gov/pubmed/28574300
http://dx.doi.org/10.1080/10717544.2017.1333170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244627/
https://www.ncbi.nlm.nih.gov/pubmed/28574300
http://dx.doi.org/10.1080/10717544.2017.1333170

Ejemplares similares